How the COVID 19 pandemic will shape influenza public health initiatives: The UK experience

References

• Public Health England. Surveillance of influenza and other seasonal respiratory viruses in the UK: winter 2020 to 2021. London: Public Health England; 2021.
   Google Scholar
• Karlsson EA, Mook PAN, Vandemaele K, Fitzner J, Hammond A, Cozza V, et al. Review of global influenza circulation, late 2019 to 2020, and the impact of the COVID-19 pandemic on influenza circulation. Releve Epidemiologique Hebd. 2021;96:241–8.
   Google Scholar
• Academy of Medical Sciences. COVID-19: preparing for the future: looking ahead to winter 2021/22 and beyond. London: Academy of Medical Sciences; 2021.
   Google Scholar
• Owen J. WHO warns that averting flu pandemic may be harder as surveillance switches to covid-19. BMJ. 2020;369:m2441. doi:10.1136/bmj.m2441.
   PubMedGoogle Scholar
• He D, Zhao S, Li Y, Cao P, Gao D, Lou Y, Yang L. Comparing COVID-19 and the 1918–19 influenza pandemics in the United Kingdom. Int J Infect Dis. 2020;98:67–70. doi:10.1016/j.ijid.2020.06.075.
   PubMed Web of Science ®Google Scholar
• Johns Hopkins University Coronavirus Resource Center.
   Google Scholar
• Mansfield KE, Mathur R, Tazare J, Henderson AD, Mulick AR, Carreira H, Matthews AA, Bidulka P, Gayle A, Forbes H, et al. Indirect acute effects of the COVID-19 pandemic on physical and mental health in the UK: a population-based study. Lancet Digit Health. 2021;3(4):e217–e30. doi:10.1016/S2589-7500(21)00017-0.
   PubMedGoogle Scholar
• Public Health England. Coronavirus (COVID-19) in the UK.
   Google Scholar
• Petherick A, Goldszmidt R, Andrade EB, Furst R, Hale T, Pott A, Wood A. A worldwide assessment of changes in adherence to COVID-19 protective behaviours and hypothesized pandemic fatigue. Nat Hum Behav. 2021;5(9):1145–60. doi:10.1038/s41562-021-01181-x.
   PubMed Web of Science ®Google Scholar
• Iuliano AD, Roguski KM, Chang HH, Muscatello DJ, Palekar R, Tempia S, Cohen C, Gran JM, Schanzer D, Cowling BJ, et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet. 2018;391(10127):1285–300. doi:10.1016/S0140-6736(17)33293-2.
   PubMed Web of Science ®Google Scholar
• Public Health England. Surveillance of influenza and other respiratory viruses in the UK: winter 2019 to 2020. London: Public Health England; 2020.
   Google Scholar
• Rolfes MA, Flannery B, Chung J, O’-Halloran A, Garg S, Belongia EA, Gaglani M, Zimmerman RK, Jackson ML, Monto AS, et al. Effects of influenza vaccination in the United States during the 2017–2018 influenza season. Clin Infect Dis. 2019;69(11):1845–53. doi:10.1093/cid/ciz075.
   PubMed Web of Science ®Google Scholar
• Nichol KL, D’-Heilly SJ, Greenberg ME, Ehlinger E. Burden of influenza-like illness and effectiveness of influenza vaccination among working adults aged 50–64 years. Clin Infect Dis. 2009;48(3):292–98. doi:10.1086/595842.
   PubMed Web of Science ®Google Scholar
• Putri W, Muscatello DJ, Stockwell MS, Newall AT. Economic burden of seasonal influenza in the United States. Vaccine. 2018;36(27):3960–66. doi:10.1016/j.vaccine.2018.05.057.
   PubMed Web of Science ®Google Scholar
• Keech M, Scott AJ, Ryan PJ. The impact of influenza and influenza-like illness on productivity and healthcare resource utilization in a working population. Occup Med (Lond). 1998;48(2):85–90. doi:10.1093/occmed/48.2.85.
   PubMed Web of Science ®Google Scholar
• Nguyen JL, Yang W, Ito K, Matte TD, Shaman J, Kinney PL. Seasonal influenza infections and cardiovascular disease mortality. JAMA Cardiology. 2016;1(3):274–81. doi:10.1001/jamacardio.2016.0433.
   PubMed Web of Science ®Google Scholar
• Burki TK. Circulation of influenza, RSV, and SARS-CoV-2: an uncertain season ahead. Lancet Respir Med. 2021;9(10):e103. doi:10.1016/S2213-2600(21)00364-7.
   PubMed Web of Science ®Google Scholar
• Kumar M, Mazumder P, Mohapatra S, Kumar Thakur A, Dhangar K, Taki K, Mukherjee S, Kumar Patel A, Bhattacharya P, Mohapatra P, et al. A chronicle of SARS-CoV-2: seasonality, environmental fate, transport, inactivation, and antiviral drug resistance. J Hazard Mater. 2021;405:124043. doi:10.1016/j.jhazmat.2020.124043.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Tracking SARS-CoV-2 variants; 2022.
   Google Scholar
• Mahase E. Covid-19: omicron and the need for boosters. BMJ. 2021;375:n3079. doi:10.1136/bmj.n3079.
   PubMedGoogle Scholar
• Xie Y, Bowe B, Maddukuri G, Al-Aly Z. Comparative evaluation of clinical manifestations and risk of death in patients admitted to hospital with covid-19 and seasonal influenza: cohort study. BMJ. 2020;371:m4677. doi:10.1136/bmj.m4677.
   PubMed Web of Science ®Google Scholar
• Khorramdelazad H, Kazemi MH, Najafi A, Keykhaee M, Zolfaghari Emameh R, Falak R. Immunopathological similarities between COVID-19 and influenza: investigating the consequences of co-infection. Microb Pathog. 2021;152:104554. doi:10.1016/j.micpath.2020.104554.
   PubMed Web of Science ®Google Scholar
• Stowe J, Tessier E, Zhao H, Guy R, Muller-Pebody B, Zambon M, Andrews N, Ramsay M, Lopez Bernal J. Interactions between SARS-CoV-2 and influenza, and the impact of coinfection on disease severity: a test-negative design. Int J Epidemiol. 2021;50(4):1124–33. doi:10.1093/ije/dyab081.
   PubMed Web of Science ®Google Scholar
• Kucharski AJ, Lessler J, Cummings DAT, Riley S, Rowland-Jones S. Timescales of influenza A/H3N2 antibody dynamics. PLoS Biol. 2018;16(8):e2004974. doi:10.1371/journal.pbio.2004974.
   PubMed Web of Science ®Google Scholar
• Sridhar S, Begom S, Bermingham A, Hoschler K, Adamson W, Carman W, Bean T, Barclay W, Deeks JJ, Lalvani A, et al. Cellular immune correlates of protection against symptomatic pandemic influenza. Nat Med. 2013;19(10):1305–12. doi:10.1038/nm.3350.
   PubMed Web of Science ®Google Scholar
• Hayward AC, Wang L, Goonetilleke N, Fragaszy EB, Bermingham A, Copas A, Dukes O, Millett ERC, Nazareth I, Nguyen-Van-Tam JS, et al. Natural T Cell–mediated protection against seasonal and pandemic influenza. Results of the flu watch cohort study. Am J Respir Crit Care Med. 2015;191(12):1422–31. doi:10.1164/rccm.201411-1988OC.
   PubMed Web of Science ®Google Scholar
• Joint Committee on Vaccination and Immunisation. JCVI interim advice: potential COVID-19 booster vaccine programme winter 2021 to 2022; 2021.
   Google Scholar
• Sanz-Muñoz I, Tamames-Gómez S, Castrodeza-Sanz J, Eiros-Bouza JM, de Lejarazu-Leonardo RO. Social distancing, lockdown and the wide use of mask; a magic solution or a double-edged sword for respiratory viruses epidemiology? Vaccines. 2021;9(6):595. doi:10.3390/vaccines9060595.
   PubMed Web of Science ®Google Scholar
• Krauland MG, Galloway DD, Raviotta JM, Zimmerman RK, Roberts MS. Agent-based investigation of the impact of low rates of influenza on next season influenza infections. medRxiv. 2021. doi:10.1101/2021.08.18.21262185.
   Google Scholar
• Lee K, Jalal H, Raviotta JM, Krauland MG, Zimmerman RK, Burke DS, et al. Predicting the impact of low influenza activity in 2020 on population immunity and future influenza season in the United States. medRxiv. 2021. doi:10.1101/2021.08.29.21262803.
   Google Scholar
• Ndwandwe D, Wiysonge CS. COVID-19 vaccines. Curr Opin Immunol. 2021;71:111–16. doi:10.1016/j.coi.2021.07.003.
   PubMed Web of Science ®Google Scholar
• Comirnaty (COVID-19 Vaccine, mRNA) prescribing information. New York: Pfizer Inc.; 2021.
   Google Scholar
• Mishra S, Mindermann S, Sharma M, Whittaker C, Mellan TA, Wilton T, Klapsa D, Mate R, Fritzsche M, Zambon M, et al. Changing composition of SARS-CoV-2 lineages and rise of Delta variant in England. E Clin Med. 2021;39:101064. doi:10.1016/j.eclinm.2021.101064.
   Google Scholar
• Hills S, Eraso Y. Factors associated with non-adherence to social distancing rules during the COVID-19 pandemic: a logistic regression analysis. BMC Public Health. 2021;21(1):352. doi:10.1186/s12889-021-10379-7.
   PubMed Web of Science ®Google Scholar
• Abrams EM, Szefler SJ. COVID-19 and the impact of social determinants of health. Lancet Respir Med. 2020;8(7):659–61. doi:10.1016/S2213-2600(20)30234-4.
   PubMed Web of Science ®Google Scholar
• Sherman SM, Smith LE, Sim J, Amlôt R, Cutts M, Dasch H, Rubin GJ, Sevdalis N. COVID-19 vaccination intention in the UK: results from the COVID-19 vaccination acceptability study (CoVaccs), a nationally representative cross-sectional survey. Hum Vaccines Immuno Ther. 2021;17(6):1612–21. doi:10.1080/21645515.2020.1846397.
   PubMed Web of Science ®Google Scholar
• Allington D, McAndrew S, Moxham-Hall V, Duffy B. Coronavirus conspiracy suspicions, general vaccine attitudes, trust and coronavirus information source as predictors of vaccine hesitancy among UK residents during the COVID-19 pandemic. Psychol Med. 2021:1–12. doi:10.1017/s0033291721001434.
   PubMed Web of Science ®Google Scholar
• Ruiz JB, Bell RA. Predictors of intention to vaccinate against COVID-19: results of a nationwide survey. Vaccine. 2021;39(7):1080–86. doi:10.1016/j.vaccine.2021.01.010.
   PubMed Web of Science ®Google Scholar
• Public Health England. JCVI issues updated advice on COVID-19 booster vaccination; 2021.
   Google Scholar
• National Health Service England. Investment and impact fund 2020/21: guidance. London: National Health Service; 2020.
   Google Scholar
• Public Health England, Department of Health and Social Care. The national flu immunisation programme 2020 to 2021- update. London: National Health Service; 2020.
   Google Scholar
• Public Health England. Seasonal influenza vaccine uptake in GP patients: winter season 2020 to 2021: final data for 1 September 2020 to 28 February 2021. London: Public Health England; 2021.
   Google Scholar
• National Health Service England. Guidance: national flu immunisation programme 2021 to 2022 letter; 2021.
   Google Scholar
• National Health Service England. We’re here to help you stay well this winterwell winter. London: Public Health England; 2020.
   Google Scholar
• Edwards A. Public health England. Health matters: delivering the flu immunisation programme during the COVID-19 pandemic; 2020.
   Google Scholar
• National Health Service England. Guidance, appendix C: recommended influenza vaccines; 2021.
   Google Scholar
• World Health Organization. Recommended composition of influenza virus vaccines for use in the 2021-2022 northern hemisphere influenza season; 2021.
   Google Scholar
• Iacobucci G, Mahase E. Covid-19 vaccination: what’s the evidence for extending the dosing interval? BMJ. 2021;372:n18 doi:10.1136/bmj.n18.
   PubMedGoogle Scholar
• Lopez Bernal J, Andrews N, Gower C, Robertson C, Stowe J, Tessier E, Simmons R, Cottrell S, Roberts R, O'Doherty M, et al. Effectiveness of the Pfizer-BioNtech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study. BMJ. 2021;373(n1088). doi:10.1136/bmj.n1088.
   PubMedGoogle Scholar
• Lopez Bernal J, Andrews N, Gower C, Gallagher E, Simmons R, Thelwall S, Stowe J, Tessier E, Groves N, Dabrera G, et al. Effectiveness of Covid-19 vaccines against the B.1.617.2 (Delta) variant. N Engl J Med. 2021;385(7):585–94. doi:10.1056/NEJMoa2108891.
   PubMed Web of Science ®Google Scholar
• English PM. The UK approach to COVID-19 vaccination: why was it so different? Drugs Context. 2021;10:10. doi:10.7573/dic.2021-4-5.
   Google Scholar
• Parry H, Bruton R, Stephens C, Brown K, Amirthalingam G, Hallis B, et al. Extended interval BNT162b2 vaccination enhances peak antibody generation in older people. medRxiv 2021: 2021.05.15.21257017.
   Google Scholar
• Flaxman AD, Marchevsky N, Jenkin D, Aboagye J, Aley PK, Angus BJ, et al. Tolerability and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 (AZD1222); 2021.
   Google Scholar
• Public Health England. Flu vaccination programme 2021 to 2022: information for healthcare practitioners, 2021.
   Google Scholar
• UK Health Security Agency. When can I get my flu vaccine? Flu vaccinaiton winter 2021 to 2022; 2021.
   Google Scholar
• Office for National Statistics. Coronavirus and vaccine hesitancy, Great Britain: 9 August 2021; 2021.
   Google Scholar
• Office for National Statistics. COVID-19 vaccine refusal, UK: February to March 2021; 2021.
   Google Scholar
• Schmid P, Rauber D, Betsch C, Lidolt G, Denker ML, Cowling BJ. Barriers of iInfluenza vaccination intention and behavior – a systematic review of influenza vaccine hesitancy, 2005 – 2016. PLoS One. 2017;12(1):e0170550. doi:10.1371/journal.pone.0170550.
   PubMed Web of Science ®Google Scholar
• Smedley J, Poole J, Waclawski E, Stevens A, Harrison J, Watson J, Hayward A, Coggon D. Influenza immunisation: attitudes and beliefs of UK healthcare workers. Occup Environ Med. 2007;64(4):223–27. doi:10.1136/oem.2005.023564.
   PubMed Web of Science ®Google Scholar
• Shrikrishna D, Williams S, Restrick L, Hopkinson NS. Influenza vaccination for NHS staff: attitudes and uptake. BMJ Open Respir Res. 2015;2(1):e000079–e. doi:10.1136/bmjresp-2015-000079.
   PubMedGoogle Scholar
• D’-Souza G, Dowdy D. What is herd immunity and how can we achieve it with COVID-19? 2021.
   Google Scholar
• Krelle H, Tallack C. One year on: three myths about COVID-19 that the data proved wrong. London: The Health Foundation; 2021.
   Google Scholar
• Public Health England. The flu vaccination: Who should have it this winter and why; 2021.
   Google Scholar
• Williams L, Gallant AJ, Rasmussen S, Brown Nicholls LA, Cogan N, Deakin K, Young D, Flowers P. Towards intervention development to increase the uptake of COVID-19 vaccination among those at high risk: outlining evidence-based and theoretically informed future intervention content. Br J Health Psychol. 2020;25(4):1039–54. doi:10.1111/bjhp.12468.
   PubMed Web of Science ®Google Scholar
• Pebody R, Djennad A, Ellis J, Andrews N, Marques DFP, Cottrell S, et al. End of season influenza vaccine effectiveness in adults and children in the United Kingdom in 2017/18. Euro Surveill. 2019;24:1800488. doi:10.2807/1560-7917.ES.2019.24.31.1800488.
   PubMedGoogle Scholar
• Pebody R, Warburton F, Ellis J, Andrews N, Potts A, Cottrell S, et al. End-Of-Season influenza vaccine effectiveness in adults and children, United Kingdom, 2016/17. Euro Surveill. 2017;22:17–00306. doi:10.2807/1560-7917.Es.2017.22.44.17-00306.
   PubMedGoogle Scholar
• Pebody R, Warburton F, Ellis J, Andrews N, Potts A, Cottrell S, et al. Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 end-of-season results. Euro Surveill. 2016;21:30348. doi:10.2807/1560-7917.Es.2016.21.38.30348.
   PubMedGoogle Scholar
• Public Health England. Surveillance of influenza and other respiratory viruses in the UK: winter 2018 to 2019. London: Public Health England; 2019.
   Google Scholar
• Deiss RG, Arnold JC, Chen WJ, Echols S, Fairchok MP, Schofield C, Danaher PJ, McDonough E, Ridoré M, Mor D, et al. Vaccine-Associated reduction in symptom severity among patients with influenza A/H3N2 disease. Vaccine. 2015;33(51):7160–67. doi:10.1016/j.vaccine.2015.11.004.
   PubMed Web of Science ®Google Scholar
• Thompson MG, Pierse N, Sue Huang Q, Prasad N, Duque J, Claire Newbern E, Baker MG, Turner N, McArthur C. Influenza vaccine effectiveness in preventing influenza-associated intensive care admissions and attenuating severe disease among adults in New Zealand 2012–2015. Vaccine. 2018;36(39):5916–25. doi:10.1016/j.vaccine.2018.07.028.
   PubMed Web of Science ®Google Scholar
• Godoy P, Romero A, Soldevila N, Torner N, Jané M, Martínez A, Caylà JA, Rius C, Domínguez A. Influenza vaccine effectiveness in reducing severe outcomes over six influenza seasons, a case-case analysis, Spain, 2010/11 to 2015/16. Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin. 2018;23(43). doi:10.2807/1560-7917.ES.2018.23.43.1700732.
   PubMedGoogle Scholar
• Barnes GD, Cuker A, Piazza G, Siegal D. Vaccine-induced thrombotic thrombocytopenia (VITT) and COVID-19 vaccines: what cardiovascular clinicians need to know; 2021.
   Google Scholar
• Public Health England. NHS population screening: identifying and reducing inequalities; 2021.
   Google Scholar
• Public Health England. Direct and indirect impact of the vaccination programme on COVID-19 infections and mortality. London: Public Health England; 2021.
   Google Scholar
• Joint Committe on Vaccination and Immunisation. Joint Committee on Vaccination and Immunisation (JCVI) advice on third primary dose vaccination. London: Department of Health and Social Care; 2021.
   Google Scholar
• Rajaram S, Van Boxmeer J, Leav B, Suphaphiphat P, Iheanacho I, Kistler K. Retrospective evaluation of mismatch from egg-based isolation of influenza strains compared with cell-based isolation and the possible implications for vaccine effectiveness. Open Forum Infect Dis. 2018;5(suppl_1):X69. doi:10.1093/ofid/ofy209.164.
   Google Scholar
• Rockman S, Laurie KL, Parkes S, Wheatley A, Barr IG. New technologies for influenza vaccines. Microorganisms. 2020;8(11):1745. doi:10.3390/microorganisms8111745.
   PubMed Web of Science ®Google Scholar